CBD & Hemp
Southern EU export hub with a growing domestic medical market.
Greece legalised medical cannabis in 2017 and has positioned itself as both a domestic medical market and export destination. The country benefits from a favourable growing climate and has attracted significant international cultivation investment.
Greece legalised medical cannabis in 2017, rescheduling the substance from Schedule A to Schedule D following public advocacy led by patient group MAMAKA.
Cultivation and processing licensing was established through Law 4523/2018 and subsequent amendments through 2021–2023. In 2021, article 71 of Law 4864/2021 added a ban on medical cannabis imports to Law 4139/2013.
Medical cannabis products (flowers and extracts) in Greece are classified as finished pharmaceutical products requiring a full marketing authorisation from the National Organisation for Medicines (EOF) — a rigorous process requiring product development data, analytical methods, process validation, and stability risk testing.
Companies must hold both establishment approval and an operational licence, granted by the Ministers of Development & Investment, Health, and Rural Development and Food.
Who can prescribe: Specialist doctors only — initial prescriptions require specialists in Anaesthesiology, Neurology, Pathology-Oncology, Pathology-Infectiology, or Rheumatology. Repeat prescriptions may be carried out by a pathologist or GP with six-monthly specialist monitoring.
Approved conditions:
Medical cannabis is a last-resort treatment — conventional therapies must be proven infeasible, intolerable, or ineffective.
Reimbursement: None. Patients pay out-of-pocket.
Three flower strains currently available, all produced by Tikun Olam. Available in 5g and 10g packages.
Tikun Olam is the sole approved supplier. The company plans to release an extract product and expand its flower portfolio. An extract product is expected in 2025.
New operator Curity Pharma received its operational cultivation licence in March 2025. Curity's 60,700 sq m facility in Larissa Industrial Park includes a 5,000 sq m hybrid greenhouse and 1,800 sq m production facility.
Medical cannabis imports remain banned in Greece — all products on market must be domestically produced.
Tikun Olam's Greek operations consist of a 56,000 sq m facility in Examilia, including a 16,000 sq m greenhouse, a 1,000 sq m primary processing unit, and a 1,500 sq m production and packaging unit.
First exports: Tikun Olam exported its first medical cannabis products to Switzerland in November 2024. In Q1 2025, Greece exported 49 kg of medical cannabis to Germany.
Domestic production is expanding as more companies receive operational licences.
Yes. Medical cannabis has been legal in Greece since June 2017, with commercial production licences available since 2018. Greece is an emerging producer and exporter. Adult-use cannabis is not legal.